Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study

by Rendon, Adrian , Diabatem, Ousmane Ibrahim , Afifi, Magda , Siduna, Willie , Deleanu, Diana , Nyalundja, Arsene Daniel , Lao-Araya, Mongkol , Mesonjesi, Eris , Mbatchou-Ngahane, Bertrand Hugo , Hussein, Weiam , Gürgöze, Aygün , Binegdie, Amsalu , Cabrera-Sanchez, Javier , Zivkovic, Zorica , Sánchez-Angarita, Efraín , Stolbrink, Marie , Sani, Kadri , Hassan, Maged , Nantanda, Rebecca , Meghji, Jamilah , Abdulle, Osman Muhyadin , Mohammad, Yousser , Sidiki, Magassouba Aboubacar , Adam, Babiker , Liu, Yanping , Said, Bibie , Masjedi, Mohammad Reza , Mphuka, Charles Mataya , Baigabyl, Bolyskhan , Mboumi, Lydie , Hamzaoui, Agnes , Awokola, Babatunde , Ouédraogo, Abdoul Risgou , Khoo, Ee Ming , Zhang, Yutian , Catari, Juan , Ait-Khaled, Nadia , Taright, Samya , Mohammed, Mohammed , Musekiwa, Terrence Rudado , Mustafa, Ghulam , Elmustafa, Mohamed , Mbodji, Momar , Lestari, Bony Wiem , de Gula, Benilda Trias , Adeyeye, Olayinka , Mortimer, Kevin , Mpagama, Stellah , Wen, Fu-Qiang , Yunus, Faisal , Oyewusi, Lawrence , Santos, Carolina BarbosaSouza , Abusahmin, Boshra , Tayyar, Tuğçe , Saktiawati, Antonia MoritaIswari , Owiti, Peter , Hashim, Hashim Talib , Quan

in Asthma / Asthma Pharmacology / Chronic Disease / Chronic obstructive pulmonary disease / COPD Pharmacology / Costs / Cross-Sectional Studies / Data collection / Developing Countries / Drug Costs / Drug dosages / Drug stores / Drugs, Essential - economics / Drugs, Essential - supply & distribution / Drugs, Essential - therapeutic use / Health disparities / Health Economist / Health facilities / Health Services Accessibility - economics / Humans / Inhalers / LDCs / Low income groups / Medicine / Middle income / Morbidity / Mortality / Pharmacology / Pharmacy / Respiratory diseases / Respiratory Tract Diseases - drug therapy / Respiratory Tract Diseases - economics / Short Report / Steroids / Sustainable development

2024

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study

2024

Confirm

Do you wish to request the book?

Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study

2024

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study

Rendon, Adrian,

Diabatem, Ousmane Ibrahim,

Afifi, Magda,

Siduna, Willie,

Deleanu, Diana,

Nyalundja, Arsene Daniel,

Lao-Araya, Mongkol,

Mesonjesi, Eris,

Mbatchou-Ngahane, Bertrand Hugo,

Hussein, Weiam,

Gürgöze, Aygün,

Binegdie, Amsalu,

Cabrera-Sanchez, Javier,

Zivkovic, Zorica,

Sánchez-Angarita, Efraín,

Stolbrink, Marie,

Sani, Kadri,

Hassan, Maged,

Nantanda, Rebecca,

Meghji, Jamilah,

Abdulle, Osman Muhyadin,

Mohammad, Yousser,

Sidiki, Magassouba Aboubacar,

Adam, Babiker,

Liu, Yanping,

Said, Bibie,

Masjedi, Mohammad Reza,

Mphuka, Charles Mataya,

Baigabyl, Bolyskhan,

Mboumi, Lydie,

Hamzaoui, Agnes,

Awokola, Babatunde,

Ouédraogo, Abdoul Risgou,

Khoo, Ee Ming,

Zhang, Yutian,

Catari, Juan,

Ait-Khaled, Nadia,

Taright, Samya,

Mohammed, Mohammed,

Musekiwa, Terrence Rudado,

Mustafa, Ghulam,

Elmustafa, Mohamed,

Mbodji, Momar,

Lestari, Bony Wiem,

de Gula, Benilda Trias,

Adeyeye, Olayinka,

Mortimer, Kevin,

Mpagama, Stellah,

Wen, Fu-Qiang,

Yunus, Faisal,

Oyewusi, Lawrence,

Santos, Carolina BarbosaSouza,

Abusahmin, Boshra,

Tayyar, Tuğçe,

Saktiawati, Antonia MoritaIswari,

Owiti, Peter,

Hashim, Hashim Talib,

Quan

2024

Overview

Contemporary data on the availability, cost and affordability of essential medicines for chronic respiratory diseases (CRDs) across low-income and middle-income countries (LMICs) are missing, despite most people with CRDs living in LMICs. Cross-sectional data for seven CRD medicines in pharmacies, healthcare facilities and central medicine stores were collected from 60 LMICs in 2022–2023. Medicines for symptomatic relief were widely available and affordable, while preventative treatments varied widely in cost, were less available and largely unaffordable. There is an urgent need to address these issues if the Sustainable Development Goal 3 is to be achieved for people with asthma by 2030.

Share this book

Add to My Shelf

Publisher

BMJ Publishing Group Ltd and British Thoracic Society,BMJ Publishing Group LTD,BMJ Publishing Group

Subject

Asthma

/ Asthma Pharmacology

/ Chronic Disease

/ Chronic obstructive pulmonary disease

/ COPD Pharmacology

/ Costs

/ Cross-Sectional Studies